Signosis is a leading global provider of molecular tools for biomarker discovery and analysis in life science research, clinic application, and drug discovery. Their products target biomarkers such as disease-related proteins, mRNAs, microRNAs, epigenetic variations, and SNP. Signosis works with renowned research institutions like Stanford Medicine, National Institute of Mental Health, Stratech, Genentech, and Harvard to enable pioneering research discoveries.